In a clinical study, GammaTile Therapy extended the time of a tumor reemerging with limited side effects.
“I think it’s going to be a major game changer for patients who have tumors that have spread from elsewhere in their body,” Dr. Michael Horowitz, a neurosurgeon specialist at HCA Florida Orange Park Hospital, said.
“I was amazed at the hospital to see Dr. Horowitz,” Vigil said. “He said I can help you. And I said let’s do it.”“The area where I took the tumor out, since the patient could not get any more radiation the traditional way because it would have damaged the brain, so instead, I put the gamma tiles in to just give local radiation to the cavity and the wall of the cavity where I took the tumor out.”
According to medical experts, more than 200,000 people a year are diagnosed with some form of brain cancer. More than half of the patients treated for a brain tumor learn the tumor grows back within the same year– despite aggressive therapies.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Brain Cancer Breakthrough: Glioblastoma Therapy Doubles Down on Tumor DestructionA groundbreaking new study introduces a promising therapy for glioblastoma that combines oncolytic virus injections into tumors with intravenous immunotherapy. The treatment, which is safe and effective, demonstrated prolonged survival for select patients and a genetic signature that may predict who
Lire la suite »
Sorry, the government’s not paying for your therapy appMakers of products that take medicine online say slow-moving bureaucracy is crushing innovation.
Lire la suite »
Harvard Researchers Design “Mini Gene” Therapy for Severe Genetic DiseaseResearchers have developed a 'mini gene' therapy for a debilitating syndrome that results in both blindness and deafness. Usher Syndrome type 1F is a rare, debilitating genetic disorder characterized by deafness, impaired balance, and the gradual deterioration of vision. Now, a team of researche
Lire la suite »
Episode 1: When Is CAR T-Cell Therapy the Answer?Drs AmeliaLangston and MelodySmithMD provide an overview of CARTcellTherapy, the products available, potential complications, and what's next in this rapidly advancing field. Immunotherapy CancerTreatment
Lire la suite »
Sarepta stock soars 30% premarket after FDA panel backs accelerated approval for Duchenne muscular dystrophy therapySarepta Therapeutics Inc.’s stock soared 30% premarket Monday, after a U.S. Food and Drug Administration panel voted 8-6 in favor of accelerated approval for...
Lire la suite »
Sarepta surges after FDA panel backs Duchenne gene therapyShares of Sarepta Therapeutics jumped 25% on Monday as a backing by the U.S. health regulator's advisers increased the certainty of an accelerated approval for the company's gene therapy for a muscle-wasting genetic disorder.
Lire la suite »